Analyst Recommendations

15.58 -0.26(-1.64%)07/03/2024
Acadia Pharmaceuticals Inc (ACAD)


2024: Total Recommendations Consensus
To Grade# of Recommendations
Buy12
Overweight9
Outperform6
Neutral4
Perform3
Market Outperform1
Hold1

5 records were shown. To view all data, Upgrade to PRO plan with only $1


Upgrades & Downgrades